Glutaminase is essential for the growth of triple-negative breast cancer cells with a deregulated glutamine metabolism pathway and its suppression synergizes with mTOR inhibition-Reference-Cited by-同舟云学术

Glutaminase is essential for the growth of triple-negative breast cancer cells with a deregulated glutamine metabolism pathway and its suppression synergizes with mTOR inhibition

Published:2017-09-26 Issue:9 Volume:12 Page:e0185092
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Lampa Michael,Arlt Heike,He Timothy,Ospina Beatriz,Reeves Jason,Zhang Bailin,Murtie Joshua,Deng Gejing,Barberis Claude,Hoffmann Dietmar,Cheng Hong,Pollard Jack,Winter Christopher,Richon Victoria,Garcia-Escheverria Carlos,Adrian Francisco,Wiederschain Dmitri,Srinivasan Lakshmi^ORCID

Funder

Sanofi

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference54 articles.

1. Hallmarks of cancer: the next generation;D Hanahan;Cell,2011

2. Regulation of cancer cell metabolism;RA Cairns;Nat Rev Cancer,2011

3. Understanding the Warburg effect: the metabolic requirements of cell proliferation;MG Vander Heiden;Science,2009

4. Glutamine addiction: a new therapeutic target in cancer;DR Wise;Trends Biochem Sci,2010

5. Relevance of glutamine metabolism to tumor cell growth;MA Medina;Molecular and cellular biochemistry,1992

Cited by 115 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Free Salivary Amino Acid Profile in Breast Cancer: Clinicopathological and Molecular Biological Features;Current Issues in Molecular Biology;2024-06-05

2. Oxidative Stress in Breast Cancer: A Biochemical Map of Reactive Oxygen Species Production;Current Issues in Molecular Biology;2024-05-13

3. Anticancer Effects of the Trivalent Organoarsenical 2-Amino-4-(dihydroxyarsinoyl) Butanoate;Organometallics;2024-05-08

4. Wild-type IDH2 is a therapeutic target for triple-negative breast cancer;Nature Communications;2024-04-24

5. Everolimus decreases [U-13C]glucose utilization by pyruvate carboxylase in breast cancer cells in vitro and in vivo;Biomedicine & Pharmacotherapy;2024-04